Product Information
THEOPHYLLINE ER 300 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.3324 per EA under NDC 64380024301. Its NADAC has been published 86 times since Nov 6, 2024.
Strength
300 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380024301
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
THEOPHYLLINE ANHYDROUSApproval Type
Generic (ANDA)
FDA Application
ANDA215312On Market Since
9/27/2024
Pharmacological Classes
Price Statistics
The NADAC for THEOPHYLLINE ER 300 MG TABLET has been published 86 times since Nov 6, 2024, and over the history we have for it it has declined 68.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3324 per EA |
|---|---|
| All-time high | $1.0440 (Nov 13, 2024) |
| All-time low | $0.3196 (May 20, 2026) |
| 52-week high | $0.6132 |
| 52-week low | $0.3196 |
| Median price | $0.5059 |
| Average price | $0.5082 |
| Largest weekly change | -44.1% (Nov 20, 2024) |
| Weeks tracked | 86 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of THEOPHYLLINE ER 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for THEOPHYLLINE ER 300 MG TABLET, manufactured by Strides Pharma Inc., is $0.3324 per EA (NDC 64380024301), effective Jun 24, 2026.
How has the price of THEOPHYLLINE ER 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for THEOPHYLLINE ER 300 MG TABLET has declined 68.2%. It has been tracked across 86 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for THEOPHYLLINE ER 300 MG TABLET?
Since Nov 6, 2024, the NADAC for THEOPHYLLINE ER 300 MG TABLET has ranged from a low of $0.3196 (May 20, 2026) to a high of $1.0440 (Nov 13, 2024), with a median of $0.5059 per EA.
Are there cheaper alternatives to THEOPHYLLINE ER 300 MG TABLET?
9 NADAC-published products share the same active ingredient, strength, and dosage form as THEOPHYLLINE ER 300 MG TABLET, but none are currently priced below it.
Who manufactures THEOPHYLLINE ER 300 MG TABLET?
THEOPHYLLINE ER 300 MG TABLET (NDC 64380024301) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification